Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
4.070
+0.090 (2.26%)
May 14, 2026, 4:00 PM EDT - Market closed

Cellectis Revenue

Cellectis had revenue of $7.55M in the quarter ending March 31, 2026, a decrease of -37.25%. This brings the company's revenue in the last twelve months to $75.11M, up 37.20% year-over-year. In the year 2025, Cellectis had annual revenue of $79.59M with 61.72% growth.

Revenue (ttm)
$75.11M
Revenue Growth
+37.20%
P/S Ratio
4.03
Revenue / Employee
$328,000
Employees
229
Market Cap
302.50M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202579.59M30.38M61.72%
Dec 31, 202449.22M40.02M435.37%
Dec 31, 20239.19M-16.53M-64.26%
Dec 31, 202225.72M-12.87M-33.35%
Dec 31, 202138.60M-20.97M-35.20%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Niagen Bioscience130.42M
Editas Medicine38.69M
OmniAb28.94M
Zentalis Pharmaceuticals26.87M
AC Immune4.62M
Revenue Rankings